CoChat

Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival

Open access
Cartlidge, Robert A., Thomas, G. R., Cagnol, Sebastien, Jong, Kimberly A., Molton, Sarah A., Finch, Andrew J., McMahon, Martin · 2008 · Pigment Cell & Melanoma Research
Cited by 116

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: Somatic activating mutations of BRAF are the earliest and most common genetic abnormality detected in the genesis of human melanoma. However, the mechanism(s) by which activated BRAF promotes melanoma cell cycle progression and/or survival remain unclear. Here we demonstrate that expression of BIM, a pro‐apoptotic member of the BCL‐2 family, is inhibited by BRAF→MEK→ERK signaling in mouse and human melanocytes and in human melanoma cells. Trophic factor deprivation of melanocytes leads to elevated BIM expression. However, re‐addition of trophic factors or activation of a conditional form of BRAFV600E leads to rapid inhibition of BIM expression. In both cases, inhibition of BIM expression was dependent on the activity of MEK1/2 and the proteasome. Consistent with these observations, pharmacological inhibition of BRAF V600E or MEK1/2 in human melanoma cells (using PLX4720 and CI‐1040 respectively) led to a striking elevation of BIM expression. Re‐activation of BRAF→MEK→ERK signaling led to phosphorylation of BIM‐EL on serine 69 and its subsequent degradation. Interestingly, endogenous expression of BIM in melanoma cells was insufficient to induce apoptosis unless combined with serum deprivation. Under these circumstances, inhibition of BIM expression by RNA interference provided partial protection from apoptosis. These data suggest that regulation of BIM expression by BRAF→MEK→ERK signaling is one mechanism by which oncogenic BRAF V600E can influence the aberrant physiology of melanoma cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1755-148x.2008.00491.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 116

Metadata

Authors
Cartlidge, R. A., Thomas, G. R., Cagnol, S., Jong, K. A., Molton, S. A., Finch, A. J., & McMahon, M.
Venue
Pigment Cell & Melanoma Research
Publisher
Wiley
Published
2008-09-18
Volume
21
Issue
5
Pages
534-544
ISSN
  • 1755-1471 (ISSN-L)
  • 1755-148X
OpenAlex
W1821265034
Cited by
116
References
4
FWCI
3.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival. https://app.cochat.ai/papers/10.1111/j.1755-148x.2008.00491.x
The paper
Cartlidge, R. A., Thomas, G. R., Cagnol, S., Jong, K. A., Molton, S. A., Finch, A. J., & McMahon, M. (2008). Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival. Pigment Cell & Melanoma Research. https://doi.org/10.1111/j.1755-148x.2008.00491.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.